Handelsbanken Fonder AB Decreases Stock Position in The Cooper Companies, Inc. $COO

Handelsbanken Fonder AB lowered its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 57.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 69,947 shares of the medical device company’s stock after selling 93,113 shares during the quarter. Handelsbanken Fonder AB’s holdings in Cooper Companies were worth $5,733,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Bell Investment Advisors Inc lifted its stake in Cooper Companies by 106.3% in the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after purchasing an additional 219 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new stake in Cooper Companies in the 2nd quarter worth $36,000. True Wealth Design LLC lifted its stake in Cooper Companies by 484.8% in the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after purchasing an additional 383 shares in the last quarter. Cromwell Holdings LLC lifted its stake in Cooper Companies by 128.8% in the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after purchasing an additional 273 shares in the last quarter. Finally, Board of the Pension Protection Fund purchased a new stake in Cooper Companies in the 4th quarter worth $41,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

COO has been the topic of several research analyst reports. William Blair upgraded shares of Cooper Companies to a “strong-buy” rating in a research note on Friday, January 30th. Citigroup decreased their price target on shares of Cooper Companies from $88.00 to $87.00 and set a “neutral” rating on the stock in a research note on Friday, March 6th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. Barclays upped their target price on shares of Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, March 6th. Finally, Needham & Company LLC upped their target price on shares of Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research report on Friday, March 6th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $90.79.

Cooper Companies Stock Down 0.5%

Shares of NASDAQ COO opened at $62.55 on Friday. The firm’s 50-day moving average price is $66.92 and its 200-day moving average price is $75.14. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. The stock has a market capitalization of $12.20 billion, a price-to-earnings ratio of 30.97, a P/E/G ratio of 1.62 and a beta of 0.89. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.03 by $0.07. The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The business’s revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the company earned $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 4.62 EPS for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.